CDK4 and gastric cancer: Although a role for ACAA1 in gastric cancer has not been clarified, researchers observed that ACAA1 down-regulation inhibited the proliferation of triple-negative breast cancer cells and enhanced their response to CDK4/6 inhibitors (Peng et al., 2023).